Acumen Pharmaceuticals, Inc. (ABOS)
3.18
+0.09
(+2.91%)
USD |
NASDAQ |
Sep 04, 16:00
3.17
-0.01
(-0.31%)
After-Hours: 20:00
Acumen Pharmaceuticals Market Cap : 229.96M for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 229.96M |
| September 03, 2026 | 223.45M |
| September 02, 2026 | 224.18M |
| September 01, 2026 | 211.16M |
| August 31, 2026 | 206.10M |
| August 28, 2026 | 211.16M |
| August 27, 2026 | 219.11M |
| August 26, 2026 | 216.22M |
| August 25, 2026 | 224.18M |
| August 24, 2026 | 222.37M |
| August 21, 2026 | 228.51M |
| August 20, 2026 | 230.68M |
| August 19, 2026 | 227.79M |
| August 18, 2026 | 198.14M |
| August 17, 2026 | 192.36M |
| August 14, 2026 | 193.08M |
| August 13, 2026 | 184.40M |
| August 12, 2026 | 181.51M |
| August 11, 2026 | 178.62M |
| August 10, 2026 | 175.72M |
| August 07, 2026 | 176.45M |
| August 06, 2026 | 164.68M |
| August 05, 2026 | 161.79M |
| August 04, 2026 | 161.79M |
| August 03, 2026 | 157.46M |
| Date | Value |
|---|---|
| July 31, 2026 | 155.29M |
| July 30, 2026 | 156.73M |
| July 29, 2026 | 152.40M |
| July 28, 2026 | 164.68M |
| July 27, 2026 | 158.90M |
| July 24, 2026 | 153.84M |
| July 23, 2026 | 156.73M |
| July 22, 2026 | 159.62M |
| July 21, 2026 | 161.07M |
| July 20, 2026 | 159.62M |
| July 17, 2026 | 162.51M |
| July 16, 2026 | 156.73M |
| July 15, 2026 | 160.35M |
| July 14, 2026 | 182.74M |
| July 13, 2026 | 190.68M |
| July 10, 2026 | 189.96M |
| July 09, 2026 | 195.01M |
| July 08, 2026 | 197.18M |
| July 07, 2026 | 185.62M |
| July 06, 2026 | 192.85M |
| July 02, 2026 | 197.90M |
| July 01, 2026 | 187.07M |
| June 30, 2026 | 192.85M |
| June 29, 2026 | 200.07M |
| June 26, 2026 | 170.46M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 32.62B |
| ACADIA Pharmaceuticals, Inc. | 4.823B |
| Alnylam Pharmaceuticals, Inc. | 35.59B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.103B |
Market Cap Related Metrics
| Price to Book Value | 4.016 |
| Price | 3.18 |
| Earnings Yield | -51.34% |